| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9.3M | — | +129.1% |
| SG&A Expense | $5.5M | — | +45.4% |
| Operating Income | -$14.9M | — | -88.7% |
| Pre-tax Income | -$15.8M | — | -92.6% |
| Income Tax | $0 | — | — |
| Net Income | -$15.8M | — | -92.6% |
| EPS (Basic) | -$1.20 | — | -62.2% |
| EPS (Diluted) | -$1.20 | — | -62.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $206.4M | +256.0% | +172.9% |
| Short-term Investments | $55.5M | — | — |
| Current Assets | $263.2M | +346.3% | +231.4% |
| Total Assets | $263.8M | +342.9% | +232.0% |
| Current Liabilities | $9.1M | -19.6% | +1.5% |
| Total Liabilities | $31.4M | -0.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | — | -60.5% |
| Investing Cash Flow | -$55.4M | — | — |
| Financing Cash Flow | $214.7M | — | — |
| +31.8% |
| Stockholders' Equity | $232.3M | +730.2% | +318.0% |